Dihydropyrimidinase-like 2 can serve as a novel therapeutic target and prognostic biomarker in acute myeloid leukemia.
Li F, Ling Q, Lian J, Chen Y, Hu C, Yang M, Zhang X, Li C, Mao S, Ye W, Li X, Lin X, Wei W, Huang X, Pan J, Qian Y, Wang J, Lu Y, Jin J.
Li F, et al. Among authors: hu c.
Cancer Med. 2023 Apr;12(7):8319-8330. doi: 10.1002/cam4.5531. Epub 2023 Jan 9.
Cancer Med. 2023.
PMID: 36621846
Free PMC article.